|
1
|
Hightower LE: Heat shock, stress proteins,
chaperones, and proteotoxicity. Cell. 66:191–197. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pandey M, Mathew A and Nair MK: Cancer
vaccines: a step towards prevention and treatment of cancer. Eur J
Surg Oncol. 25:209–214. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hartl FU: Molecular chaperones in cellular
protein folding. Nature. 381:571–579. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Srivastava PK: Immunotherapy for human
cancer using heat shock protein-peptide complexes. Curr Oncol Rep.
7:104–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Srivastava PK: Peptide-binding heat shock
proteins in the endoplasmic reticulum: role in immune response to
cancer and in antigen presentation. Adv Cancer Res. 62:153–177.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sherman M and Multhoff G: Heat shock
proteins in cancer. Ann NY Acad Sci. 1113:192–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang C, Yu H, Wang Q, et al: Potent
antitumor effect elicited by superantigen-linked tumor cells
transduced with heat shock protein 70 gene. Cancer Sci. 95:160–167.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Srivastava PK, DeLeo AB and Old LJ: Tumor
rejection antigens of chemically induced sarcomas of inbred mice.
Proc Natl Acad Sci USA. 83:3407–3411. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Udono H, Levey DL and Srivastava PK:
Cellular requirements for tumor-specific immunity elicited by heat
shock proteins: tumor rejection antigen gp96 primes CD8+
T cells in vivo. Proc Natl Acad Sci USA. 91:3077–3081. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tamura Y, Peng P, Liu K, Daou M and
Srivastava PK: Immunotherapy of tumors with autologous
tumor-derived heat shock protein preparations. Science.
278:117–120. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vanaja DK, Grossmann ME, Celis E and Young
CY: Tumor prevention and antitumor immunity with heat shock protein
70 induced by 15-deoxy-delta12, 14-prostaglandin J2 in transgenic
adenocarcinoma of mouse prostate cells. Cancer Res. 60:4714–4718.
2000.PubMed/NCBI
|
|
12
|
Suto R and Srivastava PK: A mechanism for
the specific immunogenicity of heat shock protein-chaperoned
peptides. Science. 269:1585–1588. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Noessner E, Gastpar R, Milani V, et al:
Tumor-derived heat shock protein70 peptide complexes are
cross-presented by human dendritic cells. J Immunol. 169:5424–5432.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kumar S, Deepak P and Acharya A:
Autologous HSP70 immunization induces anti-tumor immunity and
increases longevity and survival of tumor-bearing mice. Neoplasma.
56:259–268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Manjili MH, Henderson R, Wang XY, et al:
Development of a recombinant HSP110-HER-2/neu vaccine using the
chaperoning properties of HSP110. Cancer Res. 62:1737–1742.
2002.PubMed/NCBI
|
|
16
|
Thurner B, Roder C, Dieckmann D, et al:
Generation of large numbers of fully mature and stable dendritic
cells from leukapheresis products for clinical application. J
Immunol Methods. 223:1–15. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Udono H and Srivastava PK: Heat shock
protein 70-associated peptides elicit specific cancer immunity. J
Exp Med. 178:1391–1396. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bendz H, Ruhland SC, Pandya MJ, et al:
Human heat shock protein 70 enhances tumor antigen presentation
through complex formation and intracellular antigen delivery
without innate immune signaling. J Biol Chem. 282:31688–31702.
2007. View Article : Google Scholar
|
|
19
|
Ciupitu AM, Petersson M, Kono K, Charo J
and Kiessling R: Immunization with heat shock protein 70 from
methylcholanthrene-induced sarcomas induces tumor protection
correlating with in vitro T cell responses. Cancer Immunol
Immunother. 51:163–170. 2002. View Article : Google Scholar
|
|
20
|
Chen DX, Su YR, Shao GZ and Qian ZC:
Purification of heat shock protein 70-associated tumor peptides and
their antitumor immunity to hepatoma in mice. World J
Gastroenterol. 10:361–365. 2004.PubMed/NCBI
|
|
21
|
Palladino MA Jr, Srivastatva PK, Oettgen
HF and DeLeo AB: Expression of a shared tumor-specific antigen by
two chemically induced BALB/c sarcomas. Cancer Res. 47:5074–5079.
1987.PubMed/NCBI
|
|
22
|
Srivastava PK and Udono H: Heat shock
protein-peptide complexes in cancer immunotherapy. Curr Opin
Immunol. 6:728–732. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Disis ML and Cheever MA: HER-2/neu
protein: a target for antigen-specific immunotherapy of human
cancer. Adv Cancer Res. 71:343–371. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Disis ML, Grabstein KH, Sleath PR and
Cheever MA: Generation of immunity to the HER-2/neu oncogenic
protein in patients with breast and ovarian cancer using a
peptide-based vaccine. Clin Cancer Res. 5:1289–1297.
1999.PubMed/NCBI
|
|
25
|
Lin KY, Guarnieri FG, Staveley-O’Carroll
KF, Levitsky HI, August JT, Pardoll DM and Wu TC: Treatment of
established tumors with a novel vaccine that enhances major
histocompatibility class II presentation of tumor antigen. Cancer
Res. 56:21–26. 1999.PubMed/NCBI
|
